Awareness of dying: it needs words

Por Lokker, Martine E., van Zuylen, Lia, Veerbeek, Laetitia, van der Rijt, Carin C. D., van der Heide, Agnes
Publicado em 2011

Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids

Por Oldenmenger, Wendy H., Lieverse, Paul J, Janssen, Paul J. J. M., Taal, Walter, van der Rijt, Carin C. D., Jager, Agnes
Publicado em 2011

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients

Por Kuip, Evelien J. M., Zandvliet, Maarten L., Koolen, Stijn L. W., Mathijssen, Ron H. J., van der Rijt, Carin C. D.
Publicado no Br J Clin Pharmacol (2016)

Dying at home or in an institution: perspectives of Dutch physicians and bereaved relatives

Por van der Heide, Agnes, de Vogel-Voogt, Elsbeth, Visser, Adriaan Ph., van der Rijt, Carin C. D., van der Maas, Paul J.
Publicado em 2007

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Ran...

Por Pronzato, Paolo, Cortesi, Enrico, van der Rijt, Carin C., Bols, Alain, Moreno-Nogueira, José A., de Oliveira, Carlos Freire, Barrett-Lee, Peter, Ostler, Peter J., Rosso, Ricardo
Publicado em 2010

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients

Por Oosten, Astrid W., Abrantes, João A., Jönsson, Siv, de Bruijn, Peter, Kuip, Evelien J. M., Falcão, Amílcar, van der Rijt, Carin C. D., Mathijssen, Ron H. J.
Publicado no Eur J Clin Pharmacol (2016)

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study

Por Taal, Walter, Segers-van Rijn, Joyce M. W., Kros, Johan M., van Heuvel, Irene, van der Rijt, Carin C. D., Bromberg, Jacoline E., Sillevis Smitt, Peter A. E., van den Bent, Martin J.
Publicado em 2012